OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that it has received Emergency Use ...

OraSure Technologies received emergency use authorization from the Food and Drug Administration for a new version of its ebola test. The diagnostic testing company said Tuesday it received the ...

Drug-resistant Neisseria gonorrhoeae (the bacterium that causes gonorrhea) has become one of the most urgent antimicrobial-resistant threats to public health worldwide. Clinicians expect to be ...

BILBAO, July 2 (Reuters) - The race to produce a rapid antigen test to diagnose the rare Bundibugyo Ebola virus has closed in on five possible manufacturers that could begin field trials in eastern ...

UT Dallas researchers are developing a handheld device that detects bacteria, parasites, pesticides and more in minutes — ...

A total of 47 patients had a positive result for at least two of the conventional tests, and so were considered H. pylori-positive. The IRUT showed high sensitivity (91.5%) and specificity (98.1%) and ...

Two new tests, EndoSure and Endotest, could drastically reduce the years-long wait for endometriosis diagnoses for millions ...

Rumer Willis shares how hormone tracking helped her better understand her cycle, and why she’s encouraging other women to ...

ASCORBIC acid has been found to have a marked inhibitory effect on urease activity. With some preparations of the enzyme, the formation of ammonia from urea is completely inhibited by a concentration ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

You’ll notice the language used to share stats and other data points is binary, fluctuating between the use of “male” and “female” or “men” and “women.” While we typically avoid language like this, ...

A new study in the Journal of Urgent Care Medicine (JUCM), built on 140,894 real-world Intellivisit encounters, examined a more accurate and less uncomfortable tool for ear exams — the tympanometer.